Failure of Intravesical Interferon-Alfa-2b for the Treatment of Patients with Superficial Bladder Cancer Previously Failing Intravesical BCG Therapy

By Hudson M.A.   Ratliff T.L.  

Urologic Oncology: Seminars and Original Investigations, Vol. 1, Iss. 3, 1995-05 ,pp. : 115-118

Elsevier

Access to resources Recommend Favorite

New treatment approaches for superficial and invasive bladder cancer - doses for chemoprevention trials

By Grossman H.B.   Debruyne F.M.J.   Akaza H.   Aso Y.   Kagawa S.   Kakehi Y.   van der Meijden A.P.M.   Ratliff T.L.  

Urologic Oncology: Seminars and Original Investigations, Vol. 4, Iss. 4, 1998-07 ,pp. : 183-187

Elsevier

Access to resources Recommend Favorite

Prospective clinical studies at the efficacy of brucea javanica oil, mitomycin and BCG for preventing postoperative relapse of superficial bladder cancer through perfusion

By Wang Fuli   Qin Weijun   Zhang Geng   Zhang Yuntao   Liu Heliang   Yang Lijun   Wang He   Yuan Jianlin  

The Chinese-German Journal of Clinical Oncology, Vol. 10, Iss. 4, 2011-04 ,pp. : 228-231

Springer Publishing Company

Access to resources Recommend Favorite

Differential C-erbB-2 and VEGF expression following BCG immunotherapy in superficial papillary transitional cell carcinoma of the bladder

By Morgan B.E.   Salup R.   Morgan M.B.  

Urologic Oncology: Seminars and Original Investigations, Vol. 7, Iss. 2, 2002-03 ,pp. : 67-72

Elsevier

Access to resources Recommend Favorite

Bacillus calmete-guerin plus interferon- 2B intravesical therapy maintains an extended treatment plan for superficial bladder cancer with minimal toxicity

By Lam J.S.   Benson M.C.   O'Donnell M.A.   Sawczuk A.   Gavazzi A.   Wechsler M.H.   Sawczuk I.S.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 5, 2003-09 ,pp. : 354-360

Elsevier

Access to resources Recommend Favorite